Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) - PAR-25-040
Funder
National Institutes of Health
LOI Required
No
Application Deadline
;
;
;
Maximum Project Duration
2 years
Research Focus Areas
Schizophrenia and Psychosis/Psychotic Disorders
Population Focus
Older Adults
Research Methods
Randomized Control Trials (RCT)
Description
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications that will advance translational research to better understand the emergence, trajectory, and outcomes of schizophrenia and related psychotic disorders in mid- to late-life, and to identify targets for future development of prevention and treatment interventions.